At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 47 enrolled
Drug / intervention
High Dose Drug Device +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety and Efficacy of a Drug Delivery System in Glaucoma
In Brief
A Phase 2 clinical trial evaluating High Dose Drug Device, Low Dose Drug Device, and 2 other interventions for Open-angle Glaucoma and Ocular Hypertension. Completed, enrolled 47 participants across 5 sites.
Detailed Summary
Evaluation of the ocular safety and efficacy of a drug delivery system in open-angle glaucoma or ocular hypertension.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpen-angle Glaucoma, Ocular Hypertension
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2009
First PostedNov 2009
Primary CompletionFeb 2010
TodayJul 2026
First PostedNov 19, 2009
Enrollment StartOct 1, 2009
Primary CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 16.6 years ago
Interventions
High Dose Drug Devicedrug
device inserted for 4 days
Low Dose Drug Devicedrug
device inserted for 4 days
Placebo Devicedrug
device inserted for 4 days
bimatoprost 0.03%drug
one drop in each eye on one day only